The Securities and Exchange Commission’s forthcoming executive compensation proposal would amount to a “major Ozempic diet” for required disclosures, a senior agency official said Tuesday.
The Wall Street watchdog is hoping to unveil an executive pay disclosure proposal very soon, SEC Corporation Finance Division Director Jim Moloney said at a Georgetown Law conference. He compared the plan, which was sent to the White House’s Office of Management and Budget for review in August, to the popular weight-loss drug in his remarks.